|
|
| [Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index] |
FDA News Digest
February 4, 2008
_____________________________________
IN THIS WEEK'S ISSUE
» News
-- Food, Medical Product Safety Among Key FY 'O9 FDA Budget Requests
-- Doubled Risk of Suicidal Thoughts, Behaviors Seen With Antiepileptic Use
-- FDA Approves New Drug-Eluting Stent for Opening Clogged Heart Arteries
» Upcoming Public Meetings
» Consumer Health Information
Food, Medical Product Safety Among Key FY 'O9 FDA Budget Requests
FDA is requesting nearly $2.4 billion as part of the president's fiscal year (FY) 2009 budget—a 5.7 percent increase over the current fiscal year budget. The budget proposal includes strategic increases to strengthen food protection, modernize drug safety, speed approval of generic drugs, and improve the safety and review of medical devices.
FDA has alerted health care professionals about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions. An FDA analysis of suicidality reports from placebo-controlled studies of 11 antiepileptic drugs shows that patients taking these drugs have about twice the risk of suicidal thoughts and behaviors (0.43 percent), compared with patients receiving a placebo (0.22 percent).
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01786.html
FDA Approves New Drug-Eluting Stent for Opening Clogged Heart Arteries FDA has approved the Endeavor Zotarolimus-Eluting Coronary Stent for use in treating patients with narrowed coronary arteries. The device is a tiny metal mesh tube coated with a small amount of a new drug, zotarolimus, developed only for use on a stent. It is crimped around a balloon and delivered to a narrowed section of a coronary artery through a long, thin catheter. When the stent is positioned, the balloon is inflated, expanding into the vessel wall where it will remain in place, acting as a mechanical scaffold to keep the artery open.
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01787.html To access the RSS feed of FDA news releases, go to http://www.fda.gov/bbs/topics/news/rssPress.xml. [What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
_____________________________________________ CONGRESSIONAL TESTIMONY Jan. 29 -- FDA Commissioner Andrew C. von Eschenbach, M.D., appeared before the House Subcommittee on Oversight and Investigations. Subject: "Science at FDA"
To view an archive of past testimony by FDA officials, go to http://www.fda.gov/ola/listing.html _____________________________________________
SAFETY ALERTS/RECALLS
products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go to http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
__________________________________________________________________
UPCOMING PUBLIC MEETINGS
Feb. 5 -- Cellular, Tissue and Gene Therapies Advisory Committee
Under discussion: updates of ongoing research programs
Location: Bethesda, Md., and by teleconference
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-25124.htm
Feb. 6 -- Psychopharmacologic Drugs Advisory Committee
Under discussion: pending application for a new schizophrenia treatment
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-24627.htm
For a complete list of FDA meetings, seminars, and other public events, go to
Here's what's in the spotlight this week:
› Devices That Keep the Heart Beating
http://www.fda.gov/consumer/features/cardiacdevices013008.html
› Pet Turtles: Cute but Contaminated with Salmonella
http://www.fda.gov/consumer/updates/turtles012508.html
Thanks for subscribing to FDA News Digest.
Comments about FDA News Digest?
Send an e-mail to fdanewsdigest@xxxxxxxxxv.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
[Books] [Home] [CDC News] [NIH News] [USDA News] [Photo] [Yosemite News] [Hot Springs] [Steve's Art] [Yosemite Photos] [PhotoForum] [SB Lupus] [Science Toys] [STB]
![]() |
![]() |